Shiva Analytical Warning Letter: Data In
The USFDA has issued a Warning Letter to Shiva Analyticals’ Bangalore facility following significant cGMP
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
